Paris - Delayed Quote EUR

Innate Pharma S.A. (IPH.PA)

1.9760
-0.0140
(-0.70%)
As of 9:02:10 AM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
12,621
12,621
51,901
49,580
12,110
Operating Expense
64,197
64,197
64,570
66,005
59,937
Operating Income
-51,576
-51,576
-12,669
-16,425
-47,827
Net Non Operating Interest Income Expense
1,871
1,871
2,537
258
15
Other Income Expense
232
232
2,562
-41,805
2,330
Pretax Income
-49,471
-49,471
-7,570
-57,972
-45,478
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-49,471
-49,471
-7,570
-58,103
-52,809
Diluted NI Available to Com Stockholders
-49,471
-49,471
-7,570
-58,103
-52,809
Basic EPS
-0.61
-0.61
-0.09
-0.73
-0.66
Diluted EPS
-0.61
-0.61
-0.09
-0.73
-0.66
Basic Average Shares
81,051.7980
81,051.7980
80,453.2820
79,639.8260
79,542.6270
Diluted Average Shares
81,051.7980
81,051.7980
80,453.2820
79,639.8260
79,542.6270
Total Operating Income as Reported
-51,575
-51,575
-12,669
-57,425
-47,825
Total Expenses
64,197
64,197
64,570
66,005
59,937
Net Income from Continuing & Discontinued Operation
-49,471
-49,471
-7,570
-58,103
-52,809
Normalized Income
-49,703
-49,703
-10,132
-16,167
-47,808
Interest Income
2,437
2,437
3,177
546
327
Interest Expense
566
566
640
288
312
Net Interest Income
1,871
1,871
2,537
258
15
EBIT
-48,905
-48,905
-6,930
-57,684
-45,166
EBITDA
-46,911
-46,911
-1,839
-12,279
-40,570
Reconciled Depreciation
1,994
1,994
5,091
45,405
4,596
Net Income from Continuing Operation Net Minority Interest
-49,471
-49,471
-7,570
-57,972
-45,478
Total Unusual Items Excluding Goodwill
232
232
2,562
-41,805
2,330
Total Unusual Items
232
232
2,562
-41,805
2,330
Normalized EBITDA
-47,143
-47,143
-4,401
29,526
-42,900
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 11/1/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ABNX.PA ABIONYX Pharma SA
1.2200
-0.65%
 
ADOC.PA Adocia SA
4.8250
-0.62%
 
NANO.PA Nanobiotix S.A.
3.3950
+0.89%
 
GNFT.PA Genfit S.A.
3.7820
-1.56%
 
0WA2.IL Cellectis S.A.
1.3500
+0.37%
 
6A3A.F Autolus Therapeutics plc
1.1200
-6.67%
 
5NRA.MU Nanobiotix SA
3.3200
+8.50%
 
DBV.PA DBV Technologies S.A.
2.0800
+7.00%
 
ALVIO.PA Valerio Therapeutics Société anonyme
0.0639
-1.08%
 
TNG.PA Transgene SA
0.5880
-0.34%